Your browser doesn't support javascript.
loading
HIV-1 Drug Resistance Profiles for the HIV Protease and Reverse Transcriptase Gene in Patients Receiving Combination Therapy in Tehran, Iran.
Sadeghi, Leila; Lolaie, Masoomeh; Tabatabai, Reza Adl; Bayanolhagh, Saeed; Taj, Leila; Ahmadi, Niloofar Eghbal; Abedinzadeh, Negin; Vakili, Farzaneh; Ahmadi, Ghazaleh; Mohraz, Minoo.
Afiliação
  • Sadeghi L; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
  • Lolaie M; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
  • Tabatabai RA; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
  • Bayanolhagh S; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
  • Taj L; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
  • Ahmadi NE; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
  • Abedinzadeh N; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
  • Vakili F; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
  • Ahmadi G; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
  • Mohraz M; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Infect Disord Drug Targets ; 18(3): 241-248, 2018.
Article em En | MEDLINE | ID: mdl-29663899

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Protease de HIV / HIV-1 / Farmacorresistência Viral / Transcriptase Reversa do HIV Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Infect Disord Drug Targets Assunto da revista: DOENCAS TRANSMISSIVEIS / TERAPIA POR MEDICAMENTOS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Protease de HIV / HIV-1 / Farmacorresistência Viral / Transcriptase Reversa do HIV Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Infect Disord Drug Targets Assunto da revista: DOENCAS TRANSMISSIVEIS / TERAPIA POR MEDICAMENTOS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Irã